The effect of omega-3 fatty acids and vitamin E supplementation on lipid profiles and inflammatory markers in hemodialysis patients: A systematic review of current literature

Ahila Meliana, Ameilia Anastasya Rahma Afizah, Nurina Hasanatuludhhiyah

Abstract


ABSTRAK

Latar Belakang: Kebutuhan terapi hemodialisis (HD) masih terus berkembang. Di Indonesia, HD mewakili 82% dari pelayanan cuci darah di Puskesmas Indonesia. Namun, HD menyebabkan peningkatan penanda inflamasi serta perubahan profil lipid. Kombinasi vitamin E dan asam lemak omega-3 dapat membantu mengurangi indikator inflamasi dan meningkatkan profil lipid.

Tujuan: Penelitian ini bertujuan untuk mengetahui pengaruh co-suplementasi vitamin E dan omega-3 terhadap profil lipid dan indikator inflamasi.

Metode: Penelitian ini dilakukan di PubMed dan Google Scholar untuk mencari artikel-artikel secara sistematis, Kriteria inklusi yang digunakan adalah artikel bahasa Inggris dengan uji coba terkontrol acak (RCT) dan uji coba terkontrol (CT) yang menyelidiki efek vitamin E dan omega-3 pada profil lipid dan penanda inflamasi pasien hemodialisis. Semua artikel harus diterbitkan antara September 2013 - September 2022. AM dan AA melakukan seluruh proses penelitian sebagai reviewer dan seluruh ketidaksetujuan diselesaikan bersama NH sebagai penulis ketiga.

Hasil: 1020 studi diidentifikasi dari database dan 12 artikel terpilih berdasarkan kriteria inklusi. Asam lemak omega-3 meningkatkan profil lipid, seperti kolesterol, LDL, HDL, dan trigliserida. Namun, studi ini hanya menemukan satu penelitian tentang efek vitamin E pada profil lipid. Asam lemak Omega-3 dan suplementasi vitamin E tidak memiliki efek signifikan pada penanda inflamasi, tetapi dampak suplementasi vitamin E pada tingkat IL-6 telah dilaporkan.

Kesimpulan: Co-suplementasi Omega-3 dan vitamin E berpengaruh pada penurunan level indikator inflamasi dan profil lipid pasien hemodialisis. Kami merekomendasikan bahwa studi berikutnya harus berfokus pada penelitian uji klinis mengenai pengaruh suplementasi kombinasi ini terhadap indikator inflamasi dan profil lipid pasien hemodialisis.

 

KATA KUNCI: hemodialisis; indikator inflamasi; omega-3; profil lipid; vitamin E

 

ABSTRACT

Background: Hemodialysis therapy (HD) demands is still growing. In Indonesia, HD represents 82% of dialysis services in Indonesian health centers. However, HD causes an increase in inflammatory markers as well as lipid profile changes. The combination of vitamin E and omega-3 fatty acids can assist to decrease inflammatory indicators and enhance lipid profiles.

Objectives: This study aims to investigate the effect of co-supplementation of vitamin E and omega-3 on lipid profiles and indicators of inflammation.

Methods: This study was conducted on PubMed and Google Scholar to search articles systematically. The inclusion criteria used were English articles of randomized controlled trials (RCTs) and controlled trials (CT) that investigated the effects of vitamin E and omega-3 on lipid profiles and inflammatory markers of hemodialysis patients. All articles must be published between September 2013 - September 2022. AM and AA conducted the entire research process as reviewers and all disagreements were finalized with NH as a third author.

Results: 1020 studies were identified from databases. Afterward, this study included 12 articles based on the inclusion criteria. Omega-3 fatty acids improve lipid profiles, such as cholesterol, LDL, HDL, and triglyceride. While we only found a single study about the effect of vitamin E on lipid profile. Furthermore, omega-3 fatty acids and vitamin E supplementation have no significant effect on inflammatory markers, but the impact of vitamin E supplementation on IL-6 levels was reported.

Conclusions: Co-supplementation of omega-3 and vitamin E decrease levels of inflammatory indicators and lipid profiles in hemodialysis patients. We recommend that future studies should focus on clinical trials to investigate the effect of this co-supplementation on lipid profiles and inflammatory markers of hemodialysis patients.

 

KEYWORD: hemodialysis; inflammatory markers; lipid profiles; omega-3, vitamin E


Keywords


hemodialisis; indikator inflamasi; omega-3; profil lipid; vitamin E; hemodialysis; inflammatory markers; lipid profiles; omega-3, vitamin E

Full Text:

PDF

References


Zimmerman AM. Peritoneal dialysis: increasing global utilization as an option for renal replacement therapy. Journal of global health. 2019;9(2).

van der Tol A, Stel VS, Jager KJ, Lameire N, Morton RL, Van Biesen W, et al. A call for harmonization of European kidney care: dialysis reimbursement and distribution of kidney replacement therapies. Nephrology Dialysis Transplantation. 2020;35(6): 979–986.

Kristina SA, Endarti D, Andayani TM, Aditama H. Cost of illness of hemodialysis in Indonesia: a survey from eight hospitals in Indonesia. Int J Pharm Res. 2021;13(1): 2815–2820.

Nguyen TTU, Yeom J hyun, Kim W. Beneficial effects of vitamin E supplementation on endothelial dysfunction, inflammation, and oxidative stress biomarkers in patients receiving hemodialysis: a systematic review and meta-analysis of randomized controlled trials. International Journal of Molecular Sciences. 2021;22(21): 11923.

Campo S, Lacquaniti A, Trombetta D, Smeriglio A, Monardo P. Immune System Dysfunction and Inflammation in Hemodialysis Patients: Two Sides of the Same Coin. Journal of Clinical Medicine. 2022;11(13): 3759.

Rapone B, Converti I, Santacroce L, Cesarano F, Vecchiet F, Cacchio L, et al. Impact of periodontal inflammation on nutrition and inflammation markers in hemodialysis patients. Antibiotics. 2019;8(4): 209.

Kara AV, Soylu YE. The relationship between vitamin D and inflammatory markers in maintenance hemodialysis patients. International Urology and Nephrology. 2019;51(9): 1659–1665.

Maurya NK, Sengar NS, Arya P. Impact of hemodialysis on lipid profile among chronic renal failure patients (Regular and Non Regular Haemodialysis). Int J. 2018;7: 363–365.

Ponticelli C, Arnaboldi L, Moroni G, Corsini A. Treatment of dyslipidemia in kidney transplantation. Expert Opinion on Drug Safety. 2020;19(3): 257–267. https://doi.org/10.1080/14740338.2020.1732921.

Abdel-Messeih PL, Alkady MM, Nosseir NM, Tawfik MS. Inflammatory markers in end-stage renal disease patients on haemodialysis. Journal of Medical Biochemistry. 2020;39(4): 481–487. https://doi.org/10.5937/jomb0-25120.

Valle Flores JA, Fariño Cortéz JE, Mayner Tresol GA, Perozo Romero J, Blasco Carlos M, Nestares T. Oral supplementation with omega-3 fatty acids and inflammation markers in patients with chronic kidney disease in hemodialysis. Applied Physiology, Nutrition, and Metabolism. 2020;45(8): 805–811.

Sepidarkish M, Morvaridzadeh M, Akbari-Fakhrabadi M, Almasi-Hashiani A, Rezaeinejad M, Heshmati J. Effect of omega-3 fatty acid plus vitamin E Co-Supplementation on lipid profile: A systematic review and meta-analysis. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2019;13(2): 1649–1656.

Sepidarkish M, Akbari-Fakhrabadi M, Daneshzad E, Yavari M, Rezaeinejad M, Morvaridzadeh M, et al. Effect of omega-3 fatty acid plus vitamin E Co-Supplementation on oxidative stress parameters: A systematic review and meta-analysis. Clinical Nutrition. 2020;39(4): 1019–1025.

Daud ZAM, Tubie B, Sheyman M, Osia R, Adams J, Tubie S, et al. Vitamin E tocotrienol supplementation improves lipid profiles in chronic hemodialysis patients. Vascular health and risk management. 2013;9: 747–761.

Asemi Z, Soleimani A, Shakeri H, Mazroii N, Esmaillzadeh A. Effects of omega-3 fatty acid plus alpha-tocopherol supplementation on malnutrition–inflammation score, biomarkers of inflammation and oxidative stress in chronic hemodialysis patients. International urology and nephrology. 2016;48(11): 1887–1895.

Stonehouse W, Klingner B, Tso R, Teo PS, Terefe NS, Forde CG. Bioequivalence of long-chain omega-3 polyunsaturated fatty acids from foods enriched with a novel vegetable-based omega-3 delivery system compared to gel capsules: a randomized controlled cross-over acute trial. European Journal of Nutrition. 2022;61(4): 2129–2141.

Natto ZS, Yaghmoor W, Alshaeri HK, Van Dyke TE. Omega-3 fatty acids effects on inflammatory biomarkers and lipid profiles among diabetic and cardiovascular disease patients: a systematic review and meta-analysis. Scientific reports. 2019;9(1): 1–10.

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. The BMJ. 2021;372. https://doi.org/10.1136/bmj.n71.

Tufanaru C, Munn Z, Aromataris E, Campbell J HL. JBI Manual for Evidence Synthesis. In: Aromataris E MZ (ed.) JBI; 2020. https://synthesismanual.jbi.global

Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, Currie M, Qureshi R, Mattis P, Lisy K MPF. JBI Manual for Evidence Synthesis. In: Aromataris E MZ (ed.) JBI; 2020. https://synthesismanual.jbi.global

Omrani HR, Pasdar Y, Raisi D, Najafi F, Esfandiari A. The effect of omega-3 on serum lipid profile in hemodialysis patients. Journal of Renal Injury Prevention. 2015;4(3): 68.

Gharekhani A, Dashti-Khavidaki S, Lessan-Pezeshki M, Khatami MR. Potential effects of omega-3 fatty acids on insulin resistance and lipid profile in maintenance hemodialysis patients: a randomized placebo-controlled trial. Iranian journal of kidney diseases. 2016;10(5): 310–318.

de Mattos AM, da Costa JAC, Júnior AAJ, Chiarello PG. Omega-3 fatty acid supplementation is associated with oxidative stress and dyslipidemia, but does not contribute to better lipid and oxidative status on hemodialysis patients. Journal of Renal Nutrition. 2017;27(5): 333–339.

Moeinzadeh F, Shahidi S, Mortazavi M, Dolatkhah S, Kajbaf M, Javanmard SH, et al. Effects of omega-3 fatty acid supplementation on serum biomarkers, inflammatory agents, and quality of life of patients on hemodialysis. Iranian journal of kidney diseases. 2016;10(6): 381.

Salehi Y, Moinzadeh F, Mortazavi M, Hoseini M, Dolatkhah S, Taheri S, et al. The effect of omega-3 supplementation on serum inflammatory factors in hemodialysis patients. BJMMR. 2017;20(7): 1–614.

Bashardoost B, Habibzadeh S, Shahbazzadegan B, Ahari SS, Ardabili EK, Haddad A. Effect of omega-3 supplementation on serum lipids in patients on chronic hemodialysis. International Journal of Community Medicine and Public Health. 2019;6(10): 4293.

Ahmadi A, Mazooji N, Roozbeh J, Mazloom Z, Hasanzade J. Effect of alpha-lipoic acid and vitamin E supplementation on oxidative stress, inflammation, and malnutrition in hemodialysis patients. Iranian Journal of Kidney Diseases. 2013;7(6): 461.

Zakaria H, Mostafa TM, El-Azab GA, Abd El Wahab AM, Elshahawy H, Sayed-Ahmed NAH. The impact of fish oil and wheat germ oil combination on mineral-bone and inflammatory markers in maintenance hemodialysis patients: a randomized, double-blind, placebo-controlled clinical trial. International Urology and Nephrology. 2017;49(10): 1851–1858.

Jafari T, Fallah AA, Reyhanian A, Sarmast E. Effects of pomegranate peel extract and vitamin E on the inflammatory status and endothelial function in hemodialysis patients: a randomized controlled clinical trial. Food & function. 2020;11(9): 7987–7993.

Pirhadi-Tavandashti N, Imani H, Ebrahimpour-Koujan S, Samavat S, Hakemi MS. The effect of vitamin E supplementation on biomarkers of endothelial function and inflammation among hemodialysis patients: A double-blinded randomized clinical trial. Complementary Therapies in Medicine. 2020;49: 102357.

Asemi Z, Soleimani A, Bahmani F, Shakeri H, Mazroii N, Abedi F, et al. Effect of the omega-3 fatty acid plus vitamin E supplementation on subjective global assessment score, glucose metabolism, and lipid concentrations in chronic hemodialysis patients. Molecular Nutrition and Food Research. 2016;60(2): 390–398. https://doi.org/10.1002/mnfr.201500584.

Jafari T, Fallah AA, Reyhanian A, Sarmast E. Effects of pomegranate peel extract and vitamin e on the inflammatory status and endothelial function in hemodialysis patients: A randomized controlled clinical trial. Food and Function. 2020;11(9): 7987–7993. https://doi.org/10.1039/d0fo01012j.

Calder PC. Omega-3 polyunsaturated fatty acids and inflammatory processes: Nutrition or pharmacology? British Journal of Clinical Pharmacology. 2013;75(3): 645–662. https://doi.org/10.1111/j.1365-2125.2012.04374.x.

Di Minno MND, Russolillo A, Lupoli R, Ambrosino P, Di Minno A, Tarantino G. Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease. World Journal of Gastroenterology. 2012;18(41): 5839–5847. https://doi.org/10.3748/wjg.v18.i41.5839.

Shibabaw T. Omega-3 polyunsaturated fatty acids: anti-inflammatory and anti-hypertriglyceridemia mechanisms in cardiovascular disease. Molecular and Cellular Biochemistry. 2021;476(2): 993–1003. https://doi.org/10.1007/s11010-020-03965-7.

Pirillo A, Catapano AL. Omega-3 polyunsaturated fatty acids in the treatment of hypertriglyceridaemia. International Journal of Cardiology. 2013;170(2 SUPPL.1): 6–10. https://doi.org/10.1016/j.ijcard.2013.06.040.

Chi H, Lin X, Huang H, Zheng X, Li T, Zou Y. Omega-3 fatty acid supplementation on lipid profiles in dialysis patients: Meta-analysis. Archives of Medical Research. 2014;45(6): 469–477. https://doi.org/10.1016/j.arcmed.2014.06.008.

Singh JE. Dietary sources of omega-3 fatty acids versus omega-3 fatty acid supplementation effects on cognition and inflammation. Current Nutrition Reports. 2020;9(3): 264–277.

Bowden RG, Wilson RL, Deike E, Gentile M. Fish oil supplementation lowers C-reactive protein levels independent of triglyceride reduction in patients with end-stage renal disease. Nutrition in Clinical Practice. 2009;24(4): 508–512. https://doi.org/10.1177/0884533609335376.

Flock MR, Skulas-Ray AC, Harris WS, Gaugler TL, Fleming JA, Kris-Etherton PM. Effects of supplemental long-chain omega-3 fatty acids and erythrocyte membrane fatty acid content on circulating inflammatory markers in a randomized controlled trial of healthy adults. Prostaglandins, leukotrienes, and essential fatty acids. 2014;91(4): 161–168. https://doi.org/10.1016/j.plefa.2014.07.006.

Rahman TH A, AR A, S M, AS R, SK V, Osman MT, et al. A Randomized Pilot Study on the Effects of Combined Tocotrienol-Tocopherol Mixed Fraction and Vitamin C on Inflammatory Status and Lipid Profile in Statin-Treated High Risk Patients. International Archives of Medicine. 2016; 1–12. https://doi.org/10.3823/1950.

Niki E. Role of vitamin e as a lipid-soluble peroxyl radical scavenger: In vitro and in vivo evidence. Free Radical Biology and Medicine. 2014;66: 3–12. https://doi.org/10.1016/j.freeradbiomed.2013.03.022.

Jiang Q. Natural forms of vitamin E: Metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy. Free Radical Biology and Medicine. 2014;72: 76–90. https://doi.org/10.1016/j.freeradbiomed.2014.03.035.

Sarir H, Emdadifard G, Farhangfar H, Taherichadorneshin H. Effect of vitamin e succinate on inflammatory cytokines induced by high-intensity interval training. Journal of Research in Medical Sciences. 2015;20(12): 1177–1181. https://doi.org/10.4103/1735-1995.172986.

Jafari T, Mahmoodnia L, Saeedi M. Effects of Pomegranate Peel Extract and Vitamin E on Quality of Life in Hemodialysis Patients: A Randomized Placebo-Controlled Clinical Trial. International Journal of Epidemiologic Research. 2020;7(3): 129–135. https://doi.org/10.34172/ijer.2020.23.




DOI: http://dx.doi.org/10.21927/ijnd.2023.11(1).1-10

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Indonesian Journal of Nutrition and Dietetics (IJND) indexed by:

  


Lisensi Creative Commons View My Stats